126 related articles for article (PubMed ID: 8972047)
1. Phorbol ester stimulation of equine macrophage cultures alters expression of equine infectious anemia virus.
Sellon DC; Walker KM; Russell KE; Perry ST; Fuller FJ
Vet Microbiol; 1996 Oct; 52(3-4):209-21. PubMed ID: 8972047
[TBL] [Abstract][Full Text] [Related]
2. Monocyte maturation controls expression of equine infectious anemia virus.
Maury W
J Virol; 1994 Oct; 68(10):6270-9. PubMed ID: 8083967
[TBL] [Abstract][Full Text] [Related]
3. Replication ability in vitro and in vivo of equine infectious anemia virus avirulent Japanese strain.
Zheng YH; Sentsui H; Sugita M; Nakaya T; Kishi M; Hagiwara K; Inoshima Y; Ishihara C; Kono Y; Lu JL; Ikuta K
Virology; 2000 Jan; 266(1):129-39. PubMed ID: 10612667
[TBL] [Abstract][Full Text] [Related]
4. Regulation of equine infectious anemia virus expression.
Maury W
J Biomed Sci; 1998; 5(1):11-23. PubMed ID: 9570509
[TBL] [Abstract][Full Text] [Related]
5. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
[TBL] [Abstract][Full Text] [Related]
6. Evolution of the equine infectious anemia virus long terminal repeat during the alteration of cell tropism.
Maury W; Thompson RJ; Jones Q; Bradley S; Denke T; Baccam P; Smazik M; Oaks JL
J Virol; 2005 May; 79(9):5653-64. PubMed ID: 15827180
[TBL] [Abstract][Full Text] [Related]
7. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
[TBL] [Abstract][Full Text] [Related]
8. Equine endothelial cells support productive infection of equine infectious anemia virus.
Maury W; Oaks JL; Bradley S
J Virol; 1998 Nov; 72(11):9291-7. PubMed ID: 9765477
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin treatment of equine infectious anaemia virus-infected horse macrophage cultures decreases production of infectious virus.
Smith TA; Davis E; Carpenter S
J Gen Virol; 1998 Apr; 79 ( Pt 4)():747-55. PubMed ID: 9568970
[TBL] [Abstract][Full Text] [Related]
10. Long terminal repeat sequences of equine infectious anaemia virus are a major determinant of cell tropism.
Payne SL; La Celle K; Pei XF; Qi XM; Shao H; Steagall WK; Perry S; Fuller F
J Gen Virol; 1999 Mar; 80 ( Pt 3)():755-759. PubMed ID: 10092016
[TBL] [Abstract][Full Text] [Related]
11. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
Lichtenstein DL; Issel CJ; Montelaro RC
J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
[TBL] [Abstract][Full Text] [Related]
12. Localized sequence heterogeneity in the long terminal repeats of in vivo isolates of equine infectious anemia virus.
Maury W; Perryman S; Oaks JL; Seid BK; Crawford T; McGuire T; Carpenter S
J Virol; 1997 Jul; 71(7):4929-37. PubMed ID: 9188555
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.
Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ
J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of equine infectious anemia virus virulence by identification and removal of suboptimal nucleotides.
Cook RF; Cook SJ; Berger SL; Leroux C; Ghabrial NN; Gantz M; Bolin PS; Mousel MR; Montelaro RC; Issel CJ
Virology; 2003 Sep; 313(2):588-603. PubMed ID: 12954224
[TBL] [Abstract][Full Text] [Related]
15. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
Leroux C; Issel CJ; Montelaro RC
J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
[TBL] [Abstract][Full Text] [Related]
16. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
[TBL] [Abstract][Full Text] [Related]
17. Cell specificity of the transcription-factor repertoire used by a lentivirus: motifs important for expression of equine infectious anemia virus in nonmonocytic cells.
Maury W; Bradley S; Wright B; Hines R
Virology; 2000 Feb; 267(2):267-78. PubMed ID: 10662622
[TBL] [Abstract][Full Text] [Related]
18. PU.1 binding to ets motifs within the equine infectious anemia virus long terminal repeat (LTR) enhancer: regulation of LTR activity and virus replication in macrophages.
Hines R; Sorensen BR; Shea MA; Maury W
J Virol; 2004 Apr; 78(7):3407-18. PubMed ID: 15016863
[TBL] [Abstract][Full Text] [Related]
19. Cellular and viral specificity of equine infectious anemia virus Tat transactivation.
Maury WJ; Carpenter S; Graves K; Chesebro B
Virology; 1994 May; 200(2):632-42. PubMed ID: 8178449
[TBL] [Abstract][Full Text] [Related]
20. Influence of long terminal repeat and env on the virulence phenotype of equine infectious anemia virus.
Payne SL; Pei XF; Jia B; Fagerness A; Fuller FJ
J Virol; 2004 Mar; 78(5):2478-85. PubMed ID: 14963146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
